Gestodene
Top View
- Gynaecological Uses of Dienogest Alone and in Combination with Oestrogens V
- United States Patent (10) Patent No.: US 7,297,688 B2 Grubb (45) Date of Patent: Nov
- Summary of Data Reported and Evaluation
- Combined Oral Contraceptives
- The Oestrogenic Effects of Gestodene, a Potent Contraceptive Progestin, Are Mediated by Its A-Ring Reduced Metabolites
- Nuv Aring® (Etonogestrel/Ethinyl Estradiol V Aginal Ring)
- Discerning Endometriosis As a Multifaceted Entity: a Comprehensive Review
- NHS Tayside Hormonal Contraception Guide: NHS Tayside Formulary, Pharmacological Content and Other Characteristics
- SUMMARY of PRODUCT CHARACTERISTICS 1. NAME of the MEDICINAL PRODUCT Ethinylestradiol + Gestodene Phagecon 0.015Mg/0.060 Mg Film
- X]*Premenstrual Dysphoric Disorder K584.00 Premenstrual Tension Syndrome *[X] Implies a Code Cross References to a Specific ICD10 Code
- Irritable Bowel Syndrome and Drospirenone-Containing Oral Contraceptives; a Comparative-Safety Study
- (12) United States Patent (10) Patent No.: US 8,580,771 B2 Schramm Et Al
- BP503.T. PHARMACOLOGY-II (Theory) Subject Note Prepared By
- Gestodene and Ethinylestradiol Tablets MINESSE Tablets
- Package Leaflet: Information for the User Gestodette 0.075 Mg / 0.02 Mg
- Assessment Report for Combined Hormonal Contraceptives Containing Medicinal Products
- Combined Life Cycle Assessment and Life Cycle Costing of UV-Based Treatment of Emerging Contaminants Ekaterina Rokhina, Tony Singh, Marianne Curran, Rominder Suri
- NTP Protocol